Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Alasdair Munro(University Hospital Southampton NHS Foundation Trust), Nick Andrews(Environment Agency), Vincenzo Libri, Mina Maallah, Tanveer Bawa(Guy's and St Thomas' NHS Foundation Trust), Ray Sheridan(Royal Devon & Exeter NHS Foundation Trust), Shuo Feng(University of Oxford), Alexander Hicks(Queen Alexandra Hospital), Anna L. Goodman(St Thomas' Hospital), Sue Charlton(Environment Agency), Tommy Rampling(National Institute for Health and Care Research), Leila Janani, Orod Osanlou(Betsi Cadwaladr University Health Board), Linda Harndahl(Portsmouth Hospitals NHS Trust), Marcin Bula(Broadgreen Hospital), Kyra Holliday(University of Leeds), Parvinder K. Aley(University of Oxford), Krishna Chatterjee(University of Cambridge), Stephen Saich(University Hospital Southampton NHS Foundation Trust), John Haughney(University of Aberdeen), Daniel Pan(University of Leicester), Martin Llewelyn(Brighton and Sussex Medical School), Mihaela Pacurar(University Hospital Southampton NHS Foundation Trust), Yvanne Enever, Nasir Kanji(University of Oxford), Katrina Cathie(University Hospital Southampton NHS Foundation Trust), Angela M. Minassian(National Institute for Health and Care Research), Victoria Cornelius(Imperial College London), Gavin Babbage, Mehmood Mughal(Stockport NHS Foundation Trust), Mary Ramsay(University of the Witwatersrand), Karen Regan(Bradford Teaching Hospitals NHS Foundation Trust), Shirley Todd(Royal Devon & Exeter NHS Foundation Trust), Dinesh Saralaya(Bradford Teaching Hospitals NHS Foundation Trust), Patrick Moore, David Baxter(University of Ulster), DR Owens(University Hospital Llandough), Adrian Palfreeman(University of Leicester), Ehsaan Qureshi(University Hospitals Birmingham NHS Foundation Trust), Chris Twelves(University of Leeds), Bassam Hallis(Public Health England), Agatha A. van der Klaauw(University of Cambridge), Robert C. Read(University Hospital Southampton NHS Foundation Trust), Rostam Osanlou(University of Liverpool), Kate Dodd(Broadgreen Hospital), Christopher Green(UCSF Helen Diller Family Comprehensive Cancer Center), Sunil Sharma(University Hospitals Sussex NHS Foundation Trust), Emma C. Thomson(MRC University of Glasgow Centre for Virus Research), Alastair McGregor, Yama F Mujadidi(University of Oxford)
Cited by 180